 | • レポートコード：B-MOR-08324 • 出版社/出版日：Mordor Intelligence / 2018年6月1日 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、マラリア診断の世界市場について調べ、マラリア診断の世界規模、市場動向、市場環境、技術別（臨床診断、顕微鏡診断、迅速診断検査、分子診断、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・マラリア診断の世界市場インサイト ・マラリア診断の世界市場環境 ・マラリア診断の世界市場動向 ・マラリア診断の世界市場規模 ・マラリア診断の世界市場規模：技術別（臨床診断、顕微鏡診断、迅速診断検査、分子診断、その他） ・マラリア診断の世界市場：地域別市場規模・分析 ・マラリア診断の北米市場規模・予測 ・マラリア診断のアメリカ市場規模・予測 ・マラリア診断のヨーロッパ市場規模・予測 ・マラリア診断のアジア市場規模・予測 ・マラリア診断の日本市場規模・予測 ・マラリア診断の中国市場規模・予測 ・マラリア診断のインド市場規模・予測 ・マラリア診断の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global malaria diagnostic market is expected to register a growth rate of nearly 4.5% during the forecast period, 2018-2023. The upsurge in technological advancement related to diagnostic tools with the increasing demand for treatment in malaria-endemic countries is driving this market. Based on the regional dynamics, Africa is expected to hold a lucrative pie of the market. The key factors favoring the usage of various malarial diagnostic products include the growing funding from government, rise in collaboration amongst the academic research and industry partners, and significant improvement in primary and tertiary healthcare settings.
Rising Demand for Malaria Diagnostic Tools in Malaria in Endemic Region
The rising demand for diagnostic tools in malaria is one of the primary factors driving the malaria diagnostic market. In recent years, there has been a renewed interest and commitment by World Health Organization (WHO) to eliminate the cases of malaria in around 35 countries by 2030. By 2016, WHO estimated 216 million clinical episodes, and 445,000 deaths due to malaria, globally. Thus, the need for different types of diagnostic tests plays a vital role in the detection of clinically significant malarial cases which is expected to increase the demand for the diagnostic tools for malaria detection.
Other driving factors for this market are rise in technological advancement and increasing government expenditure for novel therapeutics.
Lack of Proper Regulatory Standards
The lack of proper regulatory standards at the country levels particularly in emerging markets hinders the growth of this market. The weak regulatory framework across the emerging nations is a key concern for the manufacturers and healthcare providers. The lack of clear import export regulations can lead to the usage of substandard products can lead to further complications to the patients. Moreover, due to the lengthy registration procedures, differences in healthcare practices, the market entry parameters need to be evaluated thoroughly for investment considerations. This increases the unforced competition of manufacturers with the unregulated diagnostic test. For instance, as per a report by the WHO the Bulletin of World Health Organization more than 20% private pharmacies carried rapid diagnostic tests which were not evaluated from WHO.
Another factor hindering the market growth is lack of awareness of malaria diagnostics in developing countries.
Middle East and Africa to Retain Dominance in Malaria Diagnostics Market
The MEA region is expected to retain the highest share in the market share over the forecast period, due to the rising investment by the developed countries such as US and UK, larger patient population, coupled with the rising focus of the WHO to reduce the mortality rate of malaria in the African countries. The US accounted for 31% of the total funding for malaria elimination in Africa with approximate funding of 800million USD in 2016. In addition, rising need for early detection, and increased awareness regarding malaria diagnosis is expected to propel the demand for malaria diagnostic market in this region.
The Asia Pacific to grow at the fastest rate in the forecast period owing to the diversified patient pool, growing medical tourism industry, rising initiatives to combat malaria by the government and non-government bodies, and increasing healthcare expenditure.
Major Players – ABBOTT, ACCESS BIO, INC., BIOMÉRIEUX SA, BIO-RAD LABORATORIES, INC, NOVARTIS AG, DANAHER (BECKMAN COULTER), PREMIER MEDICAL CORPORATION PVT. LTD., SIEMENS HEALTHINEERS, AND THERMO FISHER SCIENTIFIC, amongst others.
Reasons to Purchase Malaria Diagnostics Market Report
Current and future of malaria diagnostics market outlook in the developed and emerging markets
Analysis of various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Growing Demand for Diagnostic Tools in Malaria Endemic Regions
6.1.2 Increasing Technological Advancments and Efficient Diagnostics
6.1.3 Scaup of the Rapid Diagnostic Tests and Universal Access to Diagnosis
6.2 Market Restraints
6.2.1 Increasing Number of Malaria Free Countries
6.2.2 Rising Demand for Low Cost Diagnostics Tools
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Techniques
7.1.1 Clinical Diagnostics
7.1.2 Microscopic Diagnostics
7.1.3 Rapid Diagnostic Tests
7.1.4 Molecular Diagnostics
7.1.5 Other Techniques(Serological Assays, and Drug Resistance Tests)
7.2 By Geography
7.2.1 North America
7.2.1.1 US
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 UK
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 Nigeria
7.2.4.2 South Africa
7.2.4.3 Rest of MEA
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Access Bio Inc
9.2 Alere, Inc.
9.3 Abbott
9.4 bioMérieux SA
9.5 Ortho Clinical Diagnostics
9.6 Thermo Fisher Scientific
9.7 Premier Medical Corporation Pvt Ltd
9.8 Seimens Healthineers
9.9 Bio-Rad Laboratories, Inc
9.10 Novartis AG
*List Not Exhaustive
10. Future Market Outlook